Tissue factor (TF), a transmembrane glycoprotein, functions as an essential activator of the serine protease factor Vlla. This enzymatic complex is considered to be the principal initiator of in vivo coagulation. Recent studies emphasize the role of the TF/Vlla complex in a number of pathophysiologi
Blockade by ruthenium red of tissue factor-initiated coagulation
β Scribed by Arthur J Chu; Zhen-Guo Wang; Obioma I Nwobi; Salwa Beydoun
- Book ID
- 110005738
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 167 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To investigate the effect of tissue-type plasminogen activator (t-PA) on blood coagulation, we examined the effects of the addition of t-PA to normal pool plasma (NPP) on clotting times such as diluted prothrombin time (PT) and kaolin clotting time (KCT). The diluted PT but not the KCT was significa
## Abstract ## Objective To determine whether treatment with the chimeric antiβtumor necrosis factor Ξ± antibody infliximab could reduce cellularity by the induction of apoptosis in synovial tissue. ## Methods Twentyβfour rheumatoid arthritis patients with active disease were randomized to receiv
Tissue factor (TF) serving as the receptor for coagulation factor VII (FVII) initiates the extrinsic coagulation pathway. We previously demonstrated that progesterone increases TF, coagulation and invasion in breast cancer cell lines. Herein, we investigated if tissue factor pathway inhibitor (TFPI)